LEONHARDT VENTURES NEWS
Leonhardt Ventures Announces Filing of Patent for Bioelectric S100A Expression for Organ Healing
Published: Dec 29, 2021 Mission Viejo, California, United States, Dec. 29, 2021 (GLOBE NEWSWIRE) -- Leonhardt Ventures LLC, an innovation and venture creation company focused on the convergence of bioelectrics and biologics for organ regeneration, announced...
Leonhardt Ventures Announces Issuance of Pioneering U.S. Patent for Multi-Modality Customized Bioelectric Treatment of Cancer
Published: Dec 22, 2021 Mission Viejo, California, United States, Dec. 22, 2021 (GLOBE NEWSWIRE) -- Leonhardt Ventures LLC, a pioneer in developing bioelectric and biologic innovations for organ regeneration and healing, today announced that the U.S. Patent and...
Leonhardt Ventures Files Patent for Bioelectric Diabetes Reversal Treatment via FABp4 Regulation and Klotho Regulation
Mission Viejo, CA (PRDistribution) - Dec. 30th, 2021 - Leonhardt Ventures LLC announced today filing of a patent application covering bioelectric controlled down regulation of FABp4 and up regulation of klotho for the potential purpose of reversing type 1 and...
Leonhardt’s Launchpads Accelerator To Showcase Eight Innovation Assets and Startups At 2022 Demo Day
Irvine, Calif., Nov. 16th, 2021 /PRDistribution/ -- Leonhardt's Launchpads announced today that they will showcase eight graduates of their innovation and startup launch accelerator program on a Demo Day. The event will occur both in person and virtually on Friday,...
University Lab Partners @ UCI Cove Leonhardt Custom Bioelectric Inflammation Treatment Patent Issued by USPTO
Leonhardt Ventures LLC Announces Filing of Pioneering Patent Claims for Bioelectric Signaling-Based Brain Regeneration via Controlled Expressions of BDNF, GDF10, SDF1, IGF1, and Klotho
Mission Viejo, Calif, November 1, 2021 (PRDistribution) -- Leonhardt Ventures LLC today announced the filing of additional pioneering patent claims based on the discovery in their research labs of specific bioelectric signaling sequences able to control expressions...
Leonhardt Ventures LLC Announces Plans To Take Bids for MyoStim ED ErectiStim TM Erectile Dysfunction IP and Assets
ErectiStim TM United States, California, Newport Beach, June 02, 2021 (GLOBE NEWSWIRE) -- -- Leonhardt Ventures LLC and it's innovation accelerator subsidiary Leonhardt's Launchpads by Cal-X Stars Business Accelerator, Inc. today announced that they are actively...
Leonhardt Ventures LLC Issued Pioneering Patent for Bioelectric Inflammation Treatment Device and Method
Patent protects methods and devices for customized real time treatment of chronic inflammation related disorders with bioelectric stimulation based protein expressions and control Irvine, California —(PRDistribution)- Leonhardt Ventures LLC, a clinical stage...
Leonhardt’s Launchpads Mid-Year Financials Analysis and June 2021 Financials
June 2021 Cal-X Stars Business Accelerator, Inc. Financials Mid Year 2021 Leonhardt's...
2021 Letter to Stakeholders
2021 Letter to Stakeholders A highly FOCUSED organization on the brink of major contributions to healthcare Dear Stakeholders, It is truly an honor to serve as Executive Chairman and CEO of Leonhardt’s Launchpads by Cal-X Stars Business Accelerator, Inc. the...